Investigators sought to determine how frequently information treated as confidential with regard to New Drug Applications or Biologics License Applications is available to the public.
As part of current efforts to reduce unnecessary opioid consumption, clinicians have increasingly prescribed gabapentinoids for a range of pain disorders.
The FDA is looking to make the information in the Drug Abuse and Dependence section of product labeling more consistent and clear through a new draft guidance.
A man presents to the emergency department with progressive, right-sided abdominal and flank pain for 3 days.
The use of cannabidiol (CBD), the non-intoxicating component of cannabis, has been associated with numerous adverse effects based on available evidence from animal and human studies.
The Holistic Evidence Review Board examined the merits of developing evidence-based dietary recommendations to help operators better manage pain caused by musculoskeletal injuries.
The implementation of a standardized medication regimen for pain management in incoming psychiatric inpatients may be associated with a reduction in the number of pages related to pain complaints received by on-call residents.
Due to a genetic mutation, a woman was able to endure burns, bone fractures, and surgeries without pain.
A recall of 1 lot of Ketorolac Tromethamine Injection 60mg/2mL (30mg/mL) has been initiated by Sagent Pharmaceuticals following the discovery of microbial growth during a routine simulation of the manufacturing process. Concerns over the possible introduction of microorganisms into the product led the Company to issue the recall to the user level. The product is…
Chronic widespread pain may be prevalent in patients with ankylosing spondylitis and undifferentiated spondyloarthritis.